| Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy PA Gurbel, D Erlinge, EM Ohman, B Neely, M Neely, SG Goodman, ... Jama 308 (17), 1785-1794, 2012 | 266 | 2012 |
| Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction MY Chan, JL Sun, LK Newby, LK Shaw, M Lin, ED Peterson, RM Califf, ... Circulation 119 (24), 3110-3117, 2009 | 266 | 2009 |
| Obstructive sleep apnea and cardiovascular events after percutaneous coronary intervention CH Lee, R Sethi, R Li, HH Ho, T Hein, MH Jim, G Loo, CY Koo, XF Gao, ... Circulation 133 (21), 2008-2017, 2016 | 169 | 2016 |
| Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching … S Brugaletta, T Gori, AF Low, P Tousek, E Pinar, J Gomez-Lara, ... JACC: Cardiovascular Interventions 8 (1 Part B), 189-197, 2015 | 157 | 2015 |
| Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease MY Chan, MG Cohen, CK Dyke, SK Myles, LG Aberle, M Lin, J Walder, ... Circulation 117 (22), 2865-2874, 2008 | 155 | 2008 |
| Hypercoagulable states in cardiovascular disease MY Chan, F Andreotti, RC Becker Circulation 118 (22), 2286-2297, 2008 | 141 | 2008 |
| Severe obstructive sleep apnea and outcomes following myocardial infarction CH Lee, SM Khoo, MY Chan, HB Wong, AF Low, QH Phua, AM Richards, ... Journal of Clinical Sleep Medicine 7 (6), 616-621, 2011 | 118 | 2011 |
| A randomized, repeat‐dose, pharmacodynamic and safety study of an antidote‐controlled factor IXa inhibitor MY Chan, CP Rusconi, JH Alexander, RM Tonkens, RA Harrington, ... Journal of Thrombosis and Haemostasis 6 (5), 789-796, 2008 | 115 | 2008 |
| Acute coronary syndrome in the Asia-Pacific region MY Chan, X Du, D Eccleston, C Ma, PP Mohanan, M Ogita, KG Shyu, ... international Journal of Cardiology 202, 861-869, 2016 | 112 | 2016 |
| Coronavirus-induced myocarditis: a meta-summary of cases JSY Ho, CH Sia, MYY Chan, W Lin, RCC Wong Heart & Lung 49 (6), 681-685, 2020 | 107 | 2020 |
| First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention MG Cohen, DA Purdy, JS Rossi, LR Grinfeld, SK Myles, LH Aberle, ... Circulation 122 (6), 614-622, 2010 | 93 | 2010 |
| Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: a prospective randomized study CH Lee, A Low, BC Tai, M Co, MY Chan, J Lim, YT Lim, HC Tan European heart journal 28 (1), 19-25, 2007 | 74 | 2007 |
| Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous … H Bulluck, MHH Chan, V Paradies, RL Yellon, HH Ho, MY Chan, ... Journal of Cardiovascular Magnetic Resonance 20 (1), 1-10, 2018 | 72 | 2018 |
| Prevalence, predictors, and impact of conservative medical management for patients with non–ST-segment elevation acute coronary syndromes who have angiographically documented … MY Chan, KW Mahaffey, LJ Sun, KS Pieper, HD White, PE Aylward, ... JACC: Cardiovascular Interventions 1 (4), 369-378, 2008 | 72 | 2008 |
| Effect on bleeding, time to revascularization, and one-year clinical outcomes of the radial approach during primary percutaneous coronary intervention in patients with ST … D Arzamendi, HQ Ly, JF Tanguay, MYY Chan, P Chevallereau, R Gallo, ... The American journal of cardiology 106 (2), 148-154, 2010 | 70 | 2010 |
| Antecedent risk factors and their control in young patients with a first myocardial infarction MY Chan, KS Woo, HB Wong, BL Chia, A Sutandar, HC Tan Singapore medical journal 47 (1), 27, 2006 | 69 | 2006 |
| Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI). T Kajiya, M Liang, RK Sharma, CH Lee, MY Chan, E Tay, KH Chan, ... EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2013 | 68 | 2013 |
| Plasma ceramides as prognostic biomarkers and their arterial and myocardial tissue correlates in acute myocardial infarction LP de Carvalho, SH Tan, GS Ow, Z Tang, J Ching, JP Kovalik, SC Poh, ... JACC: Basic to Translational Science 3 (2), 163-175, 2018 | 66 | 2018 |
| The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease HK Kim, US Tantry, SC Smith Jr, MH Jeong, SJ Park, MH Kim, DS Lim, ... Thrombosis and haemostasis 121 (04), 422-432, 2021 | 63 | 2021 |
| The diagnostic and prognostic potential of plasma extracellular vesicles for cardiovascular disease IEM Bank, L Timmers, CM Gijsberts, YN Zhang, A Mosterd, JW Wang, ... Expert review of molecular diagnostics 15 (12), 1577-1588, 2015 | 49 | 2015 |
